Patents by Inventor Marc E. Lanser

Marc E. Lanser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF INHIBITING ANGIOGENESIS WITH FRAGMENTS AND HOMOLOGS OF TROPONIN SUBUNIT I
    Publication number: 20090156491
    Abstract: The present invention relates to methods of inhibiting angiogenesis associated with a disease or disorder with peptides homolgous to amino acid residues 130-137 or 132-139 of human troponin subunit I.
    Type: Application
    Filed: October 20, 2008
    Publication date: June 18, 2009
    Applicants: CHILDREN'S MEDICAL CENTER CORPORATION, INC., ALSERES PHARMACEUTICALS, INC.
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I
    Patent number: 7078385
    Abstract: The present invention relates to methods of inhibiting angiogenesis associated with a disease or disorder with peptides homologous to amino acid residues 130–137 or 132–139 of human troponin subunit I.
    Type: Grant
    Filed: June 18, 2002
    Date of Patent: July 18, 2006
    Assignees: Boston Life Sciences, Inc., Children's Medical Center Corporation
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I
    Publication number: 20030186864
    Abstract: The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of troponin C, I or T subunits, fragments or homologs for the treatment of diseases or disorders involving abnormal angiogenesis and methods of use thereof.
    Type: Application
    Filed: June 18, 2002
    Publication date: October 2, 2003
    Applicant: Boston Life Sciences, Inc.
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Troponin anti-metastatic therapeutic and method of use
    Publication number: 20030157058
    Abstract: This invention comprises a method of inhibiting cancer metastases in a subject by the step of administering to said subject a therapeutically effective amount of a composition selected from the group consisting of Troponin, TnI subunits, analogs, derivatives, fragments or homologs.
    Type: Application
    Filed: January 7, 2003
    Publication date: August 21, 2003
    Inventor: Marc E. Lanser
  • Pharmaceutical compositions comprising recombinant troponin subunits
    Patent number: 6589936
    Abstract: The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of recombinant troponin C, I or T subunits for the treatment of diseases or disorders involving abnormal angiogenesis.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: July 8, 2003
    Assignee: Children's Medical Center Corporation
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Troponin subunit I fragment and homologs thereof
    Patent number: 6586401
    Abstract: The present invention relates to a peptide corresponding to human troponin subunit fragment I amino acid residues 118-137 and homologs thereof, as well as pharmaceutical compositions.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: July 1, 2003
    Assignees: Children's Medical Center Corporation, Boston Life Sciences, Inc.
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Methods of using pharmaceutical compositions comprising troponin subunits and homologs thereof before, during, or after surgical resection or radiologic ablation of a solid tumor
    Publication number: 20030119747
    Abstract: The present invention relates to methods for using pharmaceutical compositions containing troponin subunits C, I, or T in therapeutically effective amounts to inhibit angiogenesis before, during, or after surgical resection or radiologic ablation of a solid tumor. The invention also relates to using pharmaceutical compositions containing homologs of troponin subunits C, I, or T and homologs of their fragments in therapeutically effective amounts to inhibit angiogenesis before, during, or after surgical resection or radiologic ablation of a solid tumor.
    Type: Application
    Filed: November 1, 2002
    Publication date: June 26, 2003
    Inventor: Marc E. Lanser
  • Pharmaceutical compositions comprising fragments and homologs of troponin subunits
    Publication number: 20030083255
    Abstract: The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of troponin C, I or T subunits, fragments or homologs for the treatment of diseases or disorders involving abnormal angiogenesis and methods of use thereof.
    Type: Application
    Filed: July 9, 2002
    Publication date: May 1, 2003
    Applicant: Boston Life Sciences, Inc.
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
    Patent number: 6465431
    Abstract: The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of troponin C, I or T subunits, fragments, or homologs thereof, for the treatment of diseases or disorders involving abnormal angiogenesis and methods of use thereof.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: October 15, 2002
    Assignees: Boston Life Sciences, Inc., Children's Medical Center Corporation
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain